Abstract
ABSTRACT
Gut microbiota regulates neuroinflammatory responses involved in the pathogenesis of sepsis-associated encephalopathy (SAE). However, the underlying mechanism remains elusive. 16S rRNA sequencing of fecal samples revealed an expansion of the
Enterobacteriaceae
family in septic mice, and quantitative PCR further detected an increase in gut
Escherichia coli
. Subsequent bacterial transplantation experiments showed that the exacerbation of neuroinflammatory responses in sepsis by gut microbiota dysbiosis is due to the expansion of gut
E. coli
. Furthermore, we observed an increase in
E. coli
-derived 3-methylindole (3MI) in septic mice. Although 3MI alone does not directly induce neuroinflammation, it synergistically exacerbates neuroinflammatory responses with lipopolysaccharide. Mechanistically, 3MI may reduce the ubiquitination level of NLRP3 and enhance NLRP3 inflammasome activation in lipopolysaccharide-stimulated microglia. These findings suggest that
E. coli
-derived 3MI is a contributing factor in aggravating neuroinflammation in SAE, offering new insights into therapeutic strategies for SAE.
IMPORTANCE
The gut-brain axis is increasingly implicated in sepsis‑associated encephalopathy (SAE) pathogenesis, yet the precise microbial mechanisms driving neuroinflammation remain poorly defined. This study identifies a specific gut microbial pathway and reveals that sepsis-induced expansion of
Escherichia coli
and its overproduction of the metabolite 3-methylindole are key aggravating factors. Notably, while 3-methylindole alone is non-inflammatory, it acts synergistically with lipopolysaccharide to drive NLRP3 inflammasome activation in microglia, likely via reducing NLRP3 ubiquitination. These findings pinpoint a gut bacterium-derived metabolite as a critical amplifier of brain inflammation in sepsis, which contributes to a new mechanistic understanding of SAE pathogenesis.